vimarsana.com

Latest Breaking News On - Ugn 102 - Page 1 : vimarsana.com

UGN-102 With/Without TURBT Produces Similar DOR and DFS in Newly Diagnosed and Recurrent NMIBC

UroGen Pharma Says FDA Approves Plan For Rolling NDA Submission For UGN-102 From January 2024

Biotech company UroGen Pharma Ltd. (URGN) announced Tuesday that it has reached agreement with the U.S. Food and Drug Administration (FDA) on plans for submission of a New Drug Application (NDA) for UGN-102 (mitomycin) for intravesical solution.

Savanna Beef investments at N$102 million

Investments by 272 cattle producers in Savanna Beef Processors (SBP) stood at exactly N$102.78 million on Friday.The forum for the Beef Value Chain (BVCF), in a notice to members.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.